Patents by Inventor Kee Don Park

Kee Don Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10618874
    Abstract: Disclosed is a novel compound, and a cosmetic composition for whitening and a pharmaceutical composition for preventing and treating a melanin hyperpigmentation disorder by activating autophagy to induce melanosome degradation and also by effectively inhibiting endocytosis of keratinocytes to interfere melanosome transfer into keratinocytes, thereby expressing an excellent effect on improvement, prevention, and treatment of a hyperpigmentation disorder induced from melanin.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: April 14, 2020
    Assignee: INCOSPHARM CORPORATION
    Inventors: Hwa-Jee Chung, Myung Ho Kor, Heung Jae Kim, Sung Woo Kim, Seok Jeong Yoon, Ju Yeon Jung, Ka Young Shin, Se Kyoo Jeong, Kee Don Park
  • Publication number: 20190382340
    Abstract: Disclosed is a novel compound, and a cosmetic composition for whitening and a pharmaceutical composition for preventing and treating a melanin hyperpigmentation disorder by activating autophagy to induce melanosome degradation and also by effectively inhibiting endocytosis of keratinocytes to interfere melanosome transfer into keratinocytes, thereby expressing an excellent effect on improvement, prevention, and treatment of a hyperpigmentation disorder induced from melanin.
    Type: Application
    Filed: June 18, 2019
    Publication date: December 19, 2019
    Inventors: Hwa-Jee CHUNG, Myung Ho KOR, Heung Jae KIM, Sung Woo KIM, Seok Jeong YOON, Ju Yeon JUNG, Ka Young SHIN, Se Kyoo JEONG, Kee Don PARK
  • Patent number: 10463588
    Abstract: Provided are a cosmetic composition for anti-aging or alleviating skin redness, and a medicinal composition for treating and preventing skin inflammatory diseases caused by light, containing a compound inducing an increase in expression of adiponectin or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: November 5, 2019
    Assignee: Incospharm Corporation
    Inventors: Kee Don Park, Hwa-Jee Chung, Heung Jae Kim, Chae Jin Lim, Seok Jeong Yoon, Jong Phill Kang, Seon Deok Kwon, Myung Ho Kor, Ju Yeon Jung, Beom Cheol Kim, Ka Young Shin
  • Publication number: 20180303733
    Abstract: Provided are a cosmetic composition for anti-aging or alleviating skin redness, and a medicinal composition for treating and preventing skin inflammatory diseases caused by light, containing a compound inducing an increase in expression of adiponectin or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 20, 2018
    Publication date: October 25, 2018
    Inventors: Kee Don PARK, Hwa-Jee CHUNG, Heung Jae KIM, Chae Jin LIM, Seok Jeong YOON, Jong Phill KANG, Seon Deok KWON, Myung Ho KOR, Ju Yeon JUNG, Beom Cheol KIM, Ka Young SHIN
  • Patent number: 9920092
    Abstract: Provided are a composition having anti-oxidant, anti-aging, and autophagy activities to thereby be useful for preventing, alleviating, or treating age-related metabolic diseases including neurodegenerative diseases or type 2 diabetes, and uses thereof.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: March 20, 2018
    Assignee: Incospharm Corporation
    Inventors: Chae Jin Lim, Myung Ho Kor, Seok Jeong Yoon, Jin A Kim, Heung Jae Kim, Kee Don Park
  • Publication number: 20180050225
    Abstract: Provided is Youngia denticulata extract being effective for prevention and treatment of diseases caused by an environmental pollution substance, and capable of protecting cell damage.
    Type: Application
    Filed: August 7, 2017
    Publication date: February 22, 2018
    Applicant: Incospharm Corporation
    Inventors: Chae Jin LIM, Seok Jeong YOON, Myung Ho KOR, Hwa-Jee CHUNG, Ju Yeon JUNG, Ka Young SHIN, Kee Don PARK
  • Patent number: 9359401
    Abstract: The present invention relates to a peptide analog or a pharmaceutically acceptable salt thereof with excellent moisturizing effect, and use thereof for moisturization. More specifically, the present invention relates to a novel peptide analog or a pharmaceutically acceptable salt thereof, a method for preparation thereof, a moisturizing cosmetic composition comprising the same as an active ingredient, and a pharmaceutical composition for prevention and treatment of xeroderma.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: June 7, 2016
    Assignee: INCOSPHARM CORPORATION
    Inventors: Kee-Don Park, Chae-Jin Lim, Seok-Jeong Yoon, Seon-Deok Kwon
  • Patent number: 9180082
    Abstract: The present invention relates to a biotin-conjugated hexapeptide-2 derivative or a pharmaceutically acceptable salt thereof and use thereof. More particularly, the present invention relates to a biotin-conjugated hexapeptide-2 derivative or a pharmaceutically acceptable salt thereof, a preparation method thereof, a composition including the same as an active ingredient, and a method for improving wrinkles and inhibiting skin aging using the same.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: November 10, 2015
    Assignee: INCOSPHARM CORPORATION
    Inventors: Kee-Don Park, Chae-Jin Lim, Seok-Jeong Yoon, Seon-Deok Kwon
  • Publication number: 20150057230
    Abstract: The present invention relates to a biotin-conjugated hexapeptide-2 derivative or a pharmaceutically acceptable salt thereof and use thereof. More particularly, the present invention relates to a biotin-conjugated hexapeptide-2 derivative or a pharmaceutically acceptable salt thereof, a preparation method thereof, a composition including the same as an active ingredient, and a method for improving wrinkles and inhibiting skin aging using the same.
    Type: Application
    Filed: March 27, 2013
    Publication date: February 26, 2015
    Inventors: Kee-Don Park, Chae-Jin Lim, Seok-Jeong Yoon, Seon-Deok Kwon
  • Publication number: 20140113868
    Abstract: The present invention relates to a peptide analogue or a pharmaceutically acceptable salt thereof with excellent moisturizing effect, and use thereof for moisturization. More specifically, the present invention relates to a novel peptide analogue or a pharmaceutically acceptable salt thereof, a method for preparation thereof, a moisturizing cosmetic composition comprising the same as an active ingredient, and a pharmaceutical composition for prevention and treatment of xeroderma.
    Type: Application
    Filed: May 22, 2012
    Publication date: April 24, 2014
    Applicant: INCOSPHARM CORPORATION
    Inventors: Kee-Don Park, Chae-Jin Lim, Seok-Jeong Yoon, Seon-Deok Kwon
  • Patent number: 7399486
    Abstract: Disclosed is a method for preparing a mixed formulation of sustained release microspheres with various compositions by a continuous one-step process. The present method is characterized by preparing the mixed formulation of sustained release microspheres with different compositions by a continuous one-step process by continuously introducing the mixed fluids into a dryer from the two or more different fluids for preparation of sustained release microspheres containing a biodegradable polymer, a drug, an additive and a solvent with different types of contents or both of the components, by controlling the mixing ratios of the fluids according to the time, unlike a conventional method including spray-drying a mixture of microspheres containing a biodegradable polymer, a drug, an additive and a solvent with a single composition.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: July 15, 2008
    Assignee: Peptron Co., Ltd.
    Inventors: Hee Yong Lee, Sung Kyu Kim, Jung Soo Kim, Ji Suk Lee, Young Hwan Jung, Jung In Kim, Yun Mi Seo, Ho-Il Choi, Seung Gu Chang, Kee Don Park
  • Patent number: 6770470
    Abstract: The present invention describes a wastewater treatment method by a microorganism decomposing Tetramethyl Ammonium Hydroxide (TMAH) which, utilized in etching the surface of silicone chip in semiconductor manufacturing process, is toxic and hard to decompose. The present invention provides novel microorganisms capable of decomposing TMAH. Also, the present invention provides a treatment method for wastewater containing TMAH, using the microorganisms. The present invention is useful in industrial field as an environmental friendly wastewater treatment method by decomposing over 90% of TMAH, one of environmental contamination materials in the wastewater of semiconductor factory.
    Type: Grant
    Filed: March 5, 2002
    Date of Patent: August 3, 2004
    Assignee: Inbionet Corporation
    Inventors: Daesang Lee, Mi-Kyoung Lee, Key-Jung Kang, Chul-Soo Shin, Jeong-Hwan Yun, Do-Young Yum, Jung-Ki Lee, Kee-Don Park, Ho-Joon Choi, Bon-Tag Koo
  • Publication number: 20030008377
    Abstract: The present invention describes a wastewater treatment method by a microorganism decomposing Tetramethyl Ammonium Hydroxide (TMAH) which, utilized in etching the surface of silicone chip in semiconductor manufacturing process, is toxic and hard to decompose. The present invention provides novel microorganisms capable of decomposing TMAH. Also, the present invention provides a treatment method for wastewater containing TMAH, using the microorganisms. The present invention is useful in industrial field as an environmental friendly wastewater treatment method by decomposing over 90% of TMAH, one of environmental contamination materials in the wastewater of semiconductor factory.
    Type: Application
    Filed: March 5, 2002
    Publication date: January 9, 2003
    Inventors: Daesang Lee, Mi-Kyoung Lee, Key-Jung Kang, Chul-Soo Shin, Jeong-Hwan Yun, Do-Young Yum, Jung-ki Lee, Kee-Don Park, Ho-Joon Choi, Bon-tag Koo